AgenDx Biosciences Overview

  • Founded
  • 2014

Founded
  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $250K

  • Investors
  • 4

AgenDx Biosciences General Information

Description

Developer of a molecular diagnostics platform designed to offer healthcare professionals a wide range of nucleic-acid-based testing. The company's platform helps in the expansion of the commercial viability of screening, diagnosing, treatment planning, and monitoring, thus enabling healthcare professionals to offer better treatment and diagnostics for their patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Decision/Risk Analysis
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 1400 East Angela Boulevard
  • Unit 126
  • South Bend, IN 46617
  • United States

AgenDx Biosciences Timeline

2019202020212022
Financing Round

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AgenDx Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 30-Jul-2019 $250K 00.000 00.000 Completed Generating Revenue
2. Early Stage VC (Series 1) 25-Jun-2019 00.00 00.000 Completed Generating Revenue
1. Seed Round 05-Feb-2018 $1.52M $1.52M 00.000 Completed Generating Revenue
To view AgenDx Biosciences’s complete valuation and funding history, request access »

AgenDx Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
To view AgenDx Biosciences’s complete cap table history, request access »

AgenDx Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a molecular diagnostics platform designed to offer healthcare professionals a wide range of nucleic-acid-ba
Decision/Risk Analysis
South Bend, IN
00.000
0.000 0000-00-00
000000000 00.000

000000

rehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat c
0000000000000 00000000
Oakland, CA
00 As of 0000
000.00
00000000000 000.00

000000

ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore e
0000000000000 00000000
Cambridge, MA
00 As of 0000
000
000000&0 000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

AgenDx Biosciences Competitors (29)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Fabric Genomics Venture Capital-Backed Oakland, CA 00 000.00 00000000000 000.00
000000000 Corporate Backed or Acquired Cambridge, MA 00 000 000000&0 000
00000000 Venture Capital-Backed Atlanta, GA 00 00.000 00000000000 00.000
000000 Venture Capital-Backed San Francisco, CA 000 00000 000000 - 000 00000
00000 000000000 00 Venture Capital-Backed Pittsburgh, PA 00 0000 0000000000 0 0000
You’re viewing 5 of 29 competitors. Get the full list »

AgenDx Biosciences Executive Team (4)

Name Title Board Seat Contact Info
Kevin Connors Co-Founder & Chief Executive Officer
Chris Wynne Chief Financial Officer
Benjamin Miller Co-Founder
You’re viewing 3 of 4 executive team members. Get the full list »

AgenDx Biosciences Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Elevate Ventures Venture Capital Minority 000 0000 000000 0
IrishAngels Angel Group Minority 000 0000 000000 0
The Judd Leighton Foundation Limited Partner Minority 000 0000 000000 0
University Of Notre Dame USA In England University Minority 000 0000 000000 0
To view AgenDx Biosciences’s complete investors history, request access »